Posted inGenetics
“Universal” CAR-T Immunotherapy Targets Relapsed/Refractory Blood Cancers
A new type of allogeneic CAR-T cell immunotherapy that targets aggressive blood cancers has shown promising results alongside manageable side…
Posted inGenetics
StockWatch: Intellia Stumbles on News of Patient’s Severe Liver Toxicity
Intellia Therapeutics (NASDAQ: NTLA) found out this past week what other genetic medicine developers have learned in recent weeks: Any…
Posted inGenetics
Confronting a Dwindling Supply of Fetal Bovine Serum
Fetal bovine serum (FBS) has long served as a foundational input for cell culture, tissue engineering, and biomanufacturing. Yet, a…
Posted inGenetics
First IDMO Smart Factory for Commercial-Scale Cell Therapy Manufacturing Established in Japan
Cellares, in collaboration with Mitsui Fudosan, a Japanese real estate developer, established Japan’s first next-gen commercial production site for CAR-T…
Posted inGenetics
Old Vaccine, New Tricks: PIE-seq Reveals How BCG Reprograms Immunity
How can a tuberculosis vaccine also treat cancer—and potentially make other immunotherapies more effective? That’s the question researchers at Memorial…
Posted inGenetics
Neurodegeneration Slowed by Sleep Aid That Reduces Tau Buildup in Mice
Data from a new study in mice shows that a common sleep aid protects the brain from damage seen in…
Posted inGenetics
Spatial Technology Unveils Genome Structure Associated with Aging
Tapping into the structural intricacies of the cell nucleus was once a pipe dream, Jason Buenrostro, PhD, told me when…
Posted inGenetics
PEG Alternative Minimizes Immunogenicity from LNP-Based Therapies
A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by replacing a…
Posted inGenetics
Time to Intensify: Taking Process Intensification of mAb Manufacturing to the Next Level
Broadcast Date: Thursday, July 10, 2025Time: 8:00 am PT, 11:00 am ET, 17:00 CESTProcess intensification (PI) enhances the efficiency, flexibility,…
Posted inBiotechnology
Safety and Quality of CDK4/6 Inhibitors
In a groundbreaking multicenter study conducted across China, researchers have unveiled new insights into the safety and quality of life…